Chapter 6 - The Liquidation of Apex
The third floor of the Kendall Square bio-incubator smelled of autoclave steam, unpolymerized acrylic, and fifty-dollar-a-pound pour-over coffee that had gone cold in four different glass carafes.
At 8:45 on Tuesday morning, Daniel Bennett sat on an overturned plastic recycling bin in the hallway outside Suite 310, his knees pulled up toward his chest to keep his split leather shoes from touching the wet linoleum where the cleaning crew was running their floor buffers.
He had not shaved. The three-day growth along his jaw was patchy and gray with road dust, and his charcoal suit—the Anderson & Sheppard piece that had been his proudest acquisition after the Series A round—hung from his shoulders like an old coat left on an outdoor pump handle. His thumbs were raw from scrolling through his personal banking application on a seven-year-old iPhone 6 that his brother Tyler had retrieved from a junk drawer in Weymouth.
The balance on the checking screen was forty-two dollars and sixteen cents.
The door to Suite 310 swung open.
Julian Mercer did not step out; he was escorted out by two men in dark gray tactical vests bearing the embroidered insignia of the Middlesex County Sheriff’s Department / Commercial Enforcement Section. Behind them, three technicians in white Tyvek suits were systematically disconnecting the fiber-optic jumpers from the high-throughput gene-sequencing racks in the main laboratory.
Julian carried his leather briefcase under his arm like an old newspaper. His tie was missing; his collar was open at the throat, showing the red, crepey skin of his neck where his blood pressure had turned the capillaries purple.
“Julian,” Daniel rasped, scrambling to his feet so fast that his hip struck the drywall. “Did you speak to the counsel from Ropes? Did they file the injunction against the transfer of the patent assignments?”
Julian stopped. He looked at Daniel with the dull, murderous detachment of an officer looking at the private who had dropped the ammunition crates into the river.
“The patent assignments,” Julian said, his voice flat as ditch water, “were never ours, you imbecile. I spent four hours with the state appellate clerk in Cambridge at dawn. The original research charter from 2019 was executed by an entity called Sinclair Biomechatronics LLC. We weren't the owners. We were the operational management team on a three-year revocable license.”
“That’s impossible!” Daniel shouted, his voice cracking into that high, adolescent shriek that had terrified no one since his third year at prep school. “I signed the license agreement myself! I sat in the conference room at the Charles Hotel with the lawyers!”
“You signed the management contract, Daniel,” Julian said, his lip curling with an intensity that made the deputy beside him take half a step forward. “You didn't read the rider because you were too busy telling the waitress that you preferred your sparkling water at room temperature. You signed away the secondary assignment rights in exchange for an eighty-thousand-dollar personal automobile allowance and an executive membership at the University Club.”
The elevator at the end of the hall chimed.
It was not the freight car that the movers had been using. It was the private executive cab that required a biometric card to access the upper floor.
Claire Sinclair stepped out onto the linoleum.
She wore a navy-blue wool trench coat, buttoned to the chin, her hands tucked deep into the slant pockets. She wore flat leather walking boots, polished until they showed no grain, and around her neck hung a simple gold chain that disappeared into the wool of her collar.
Behind her walked Dr. Eleanor Vance, holding Noah in a front-facing carrier, while Thomas Reed carried Emma in a portable bassinet of English wicker.
Daniel took two steps toward her, his arms lifting automatically into that performative, supplicating gesture he had practiced before four different venture committees.
“Claire,” he wept. The tears were real now—not the tears of a man who had realized he had broken his wife’s heart, but the hot, terrified water that comes from the eyes of a child whose pony has been sold out from under him. “Claire, please. Look at what they’re doing to our company. This was our life. We spent five years building this platform. If you take the sequencing racks, the whole Series B round collapses before the end of the quarter.”
Claire did not stop.
She walked past him as if he were an unpainted post in an orchard, her boots making a clean, rhythmic clack-clack on the tiles.
She stopped at the glass doors of Suite 310.
Inside, twenty-four young men and women in laboratory coats were gathered around the central whiteboard, their faces pale, their hands clutching their personal laptops and lunch pails.
Claire raised her hand.
The technicians from the sheriff’s department stopped their dollies. The hum of the hydraulic lift on the freight landing died away.
“My name is Claire Sinclair,” she said through the open doorway. Her voice did not rise, but it had the weight of fifty years of family steel behind it. “I am the managing trustee of the Sinclair Medical Research Foundation. As of eight o'clock this morning, the physical assets, the clinical data, and the proprietary algorithms of this facility have been transferred to the permanent endowment of the Dana-Farber Institute.”
A young woman near the front—a post-doctoral fellow from MIT who had spent two years working sixty-hour weeks on the enzyme platform—raised her hand, her chin trembling.
“Are we... are we being fired?”
“No,” Claire said. “Your salaries have been adjusted upward by twenty-two percent to match the Harvard University instructional scale. Your health insurance has been transitioned to the central Sinclair employee trust with zero waiting period. Your contracts are permanent.”
She turned her head slightly, looking through the glass at Daniel, who remained standing on the linoleum with his mouth open, his hands hanging limp at his sides.
“The only people whose contracts have been terminated,” Claire said, “are the ones who believed that an executive title was a substitute for integrity.”
She looked at Thomas Reed.
“Thomas.”
“Yes, ma'am?”
May you like
“Have the building superintendent change the access fobs for the executive suites,” she said. “And give Mr. Mercer his yellow gloves. He left them on my table yesterday morning.”
She turned on her heel, her coat flaring slightly in the draft from the stairwell, and walked back toward the elevator without once looking down at the wet spot where Daniel Bennett’s shoes were still leaking salt water onto the floor.
